Acute and sub-acute toxicity profile of crude extract and fractions of Gymnema sylvestre

Medicinal plants have been globally used in folk medicine for the management and treatments of several diseases. With an estimate of about 80% of the world’s population relying on medicinal plants to meet their primary health care needs [1]. Medicinal plants offer attractive opportunities for drug discovery and development [2]. Furthermore, a myriad of these plants commonly used in traditional medical systems has been scientifically validated for their biological activities in in vitro and in vivo models. However, despite the growing scientific evidence of the therapeutic efficacy of medicinal plants [3], studies have indicated that the biological activities of some of these plants are concomitantly associated with adverse effects on the biological system, especially when consumed over a long period of time [4, 5]. Therefore, the safety evaluation of medicinal plants intended for use as oral remedies holds an important aspect of drug development from the natural products. The safety of these plants is, however, further jeopardized by the unhygienic and unethical processing, lack of quality controls, appropriate labeling and dosage [6]. Herbal consumers, therefore, need to be informed of the safety and appropriate use of these plants. Consequently, studies aimed at contributing to the scanty information on the possible toxic effects of these plants on the biological system are increasing [7]. Furthermore, in vivo acute, sub-acute, chronic, and sub-chronic toxicity studies are the most widely accepted experimental strategies for assessing the safety or toxicity of medicinal plants as data generated from these studies holds a translational relevance in humans.

Gymnema sylvestre is an indigenous herb of the Apocynaceae family commonly found in Africa, India, China, and Australia [8]. It is a reputable medicinal plant commonly used in traditional medicine for the treatment of diabetes, obesity, cancer, asthma, cardiovascular diseases, and several other diseases [9‐13]. Gymnemasaponins and gymnemic acids are the most recognized phytoconstituents of Gymnema sylvestre [12, 14]. The leaves of this plant contain resin, flavonoid, phytin, alkaloids, tartaric acid, anthraquinones, phenols, tannins, stigmasterol, cardiac glycosides, quinones, hentriacontane, lupeol, pentatriacontane, and β-amyrin [15‐17]. Pharmacologically, different extracts from Gymnema sylvestre have been reported for various biological activities including antidiabetic [18‐20], antioxidants [21], antimicrobial [22], anti-obesity [23], hepatoprotective [24], anti-inflammatory [25], and anticancer [26] activities. Although this plant has been proven therapeutically valuable both in the traditional medical system and experimental studies, literature survey revealed scanty scientific information on its safety and toxicity to the biological system. The objective of this study is, therefore, to investigate the effects of oral administration of crude methanol, ethyl acetate, and n-hexane fractions of Gymnema sylvestre by monitoring its effects on function indices of liver and kidney, and hematological parameters of albino rats.

Recently, much attention has been focused on using natural products as an alternative therapy for the treatment of different ailments including diabetes mellitus. Phytochemicals are bioactive plant compounds that are responsible for various biological activities and toxicological virtue [45]. The presence of significant amounts of flavonoids, alkaloids, saponins, tannins, and phenols (Tables 1 and 2) justified the traditional usage of Gymnema sylvestre for lipid-lowering purposes and for treating diabetes and obesity among others. Previous study has also indicated the presence of flavonoids, alkaloids, saponins, tannins, and phenols in methanol extract of Gymnema sylvestre [20]. The antidiabetic effect of this plant have been reportedly linked to different mechanisms involving each of the above-mentioned phytoconstituents [46]. In addition, the flavonoids, alkaloids, saponins, tannins, and phenols identified in the methanol extract of Gymnema sylvestr have been reported for antioxidant, anti-diabetics, anti-cancer, anti-microbial, anti-parasitic, anti-hypertensive, analgesic anti-inflamatory and several other biological activities [47‐50]. Though medicinal plants are widely accepted and used in the treatment of many diseases, their toxicity must not be ignored.

However, in addition to the biological activities of the phytochemicals identified in the methanol extract of Gymnema sylvestr, various studies have also linked the toxicity of various plant to the presence of these phytochemicals [45, 47, 51]. It is therefore become relevant to access the safety of Gymnema sylvestr. Acute toxicity is the adverse effects that occur within 24 h of ingesting a single dose of substance [52]. Results of the present study suggested that the crude extract, n-hexane, and ethyl-acetate fractions of G. sylvestre exhibited a high degree of safety with LD₅₀ greater than 5 kg/BW. Thus can be categorized as non-toxic extract (Class 5) in accordance to the guideline of Organization for Economic Cooperation and Development (OCED) on acute oral toxicity testing based on LD₅₀.

Kifayatullah et al. [32] however, suggested that plant extract with the high safety profile in the acute study may elicit toxic effect to the biological system upon sub-acute administration, therefore, a plant extract that is commonly used for long term management of diseases like diabetes, cancer, and high blood pressure must be further evaluated for its safety in the sub-acute treatment regime. Sub-acute toxicity is the toxicity that manifests over repeated and long term dosing of a substance, drug, or plant extract [53]. Therefore, as Gymnema sylvestre is reportedly used for long term management of diabetes, we evaluated its safety for such use.

Adverse effects arising from sub-acute plant administrations manifest on vital organs especially the liver and kidney due to their involvement in the metabolism of the substance [54]. Therefore, evaluation of biochemical parameters holds a pivotal position in assessing the integrity of the liver and kidney following possible assault from repeated administration of plant extract.

The most relevant and widely used biochemical parameters in assessing liver integrity include AST, ALT, ALP, total proteins, albumins, and bilirubins [55, 56]. These enzymes and proteins were primarily found in the liver and are released in a substantial amount to the serum when the liver’s integrity has been compromised [57, 58]. Consequently, 21 days’ administrations of crude methanol, ethyl acetate, and n-hexane fractions of Gymnema sylvestr at 300 and 600 mg/kg BW significantly upregulated the activities of AST, ALT, ALP, total proteins, and bilirubin in the serum of albino rats when compared with the non-treated control. As mentioned earlier, these upregulations of biochemical indices of liver integrity are secondary events that follow liver assault. The bioactive components in the Gymnema sylvestr crude extract and fractions must have interacted and assaulted the liver cells through a yet unidentified mechanism. However, it is clear from these findings that Gymnema sylvestr at sub-acute doses of 300 and 600 assaulted the liver and thus should be discouraged for use as an oral remedy at a dosing of 300 mg/kg BW or above.

Urea and creatinine are important excretory metabolites and are widely accepted clinical markers of kidney integrity [59]. Unfortunately, treatments of albino rats with crude methanol, ethyl acetate, and n-hexane fraction of Gymnema sylvestre at 600 mg/kg significantly decrease the serum urea concentration (Fig. 7) while increasing serum creatinine (Fig. 8) concentrations when compared with the control counterpart. This alteration is an indication of a compromised kidney function, the altered protein metabolism and expression as observed above (Fig. 3) could be implicated in the observed trends of urea concentrations following the sub-acute extract administrations. Coherently with our findings, previous studies from our lab [60, 61] and others [34] have also reported significant alterations in the levels of urea and creatinine following sub-acute dosing of plant extract at a dose of 600 mg/kg BW or above.

As a carrier of genetic materials, nutrients, metabolites across the body, the hematopoietic system is one of the most important systems in human and are most susceptible to assaults by toxic substances, including toxic metabolite from plant extracts [62, 63]. Fortunately, there was no significant difference in RBC, PCV, HB, MCV, and MCHC counts in rats treated with crude methanol, ethyl acetate, or n-hexane fraction of Gymnema sylvestre when compared with the non-treated control, suggesting that Gymnema sylvestre even at high dose does not mediate erythropoietic tendency of the animals. In line with our observation, Muhamed et al. [64] reported that the hematological profile of rats dosed N. campestris was not different from the control counterparts. However, the significant decrease in white blood cell (WBC) counts following treatments with 600 mg/kg BW crude extract and fraction suggested exhaustion of immune cells as a result of its engagement to ameliorate the stress induced by the bio-active components of the extract [63]. This will affect the animals’ ability to fight further infection and thus compromise the overall health status of the animal.

According to Berinyuy et al. [62] loss of body weight is a reliable indicator of toxicity of a compound or plant extract. Consequently, our biochemical findings on Gymnema sylvestre at 300 and 600 mg/kg BW was further strengthened by the loss of body weight of rats treated with 300 and 600 mg/kg BW of crude extract and fractions. This loss of body weight could be attributed to altered metabolism or loss of appetite, resulting in in-adequate feed intake and consequently loss of tissue protein. Its however noteworthy, that the aberrant expression and activities of biochemical parameters and WBC counts observed in rats treated with 300 and 600 mg/kg BW of crude methanol, ethyl acetate, or n-hexane fractions of Gymnema sylvestre were completely absent in rats treated with 100 mg/kg BW dose. Thus indicating the safety of this plant for both acute and sub-acute administration at 100 mg/kg BW.

In conclusion, administration of crude methanol, ethyl acetate, and n-hexane fractions of Gymnema sylvestre at sub-acute doses of 300 and 600 mg/kg BW significantly altered the serum biochemical parameters in rats. However, rats dosed with the same extracts at 100 mg/kg BW are devoid of biochemical anomalies when compared with the control counterpart. This study therefore, suggested the use of Gymnema sylvestre at dose of 100 mg/kg or below.